<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Perry-Hauser NA</submitter><funding>NEI NIH HHS</funding><funding>NIBIB NIH HHS</funding><funding>NIDA NIH HHS</funding><funding>American Heart Association-American Stroke Association</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><pagination>167465</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8977243</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>434(7)</volume><pubmed_abstract>Arrestin binding to active phosphorylated G protein-coupled receptors terminates G protein coupling and initiates another wave of signaling. Among the effectors that bind directly to receptor-associated arrestins are extracellular signal-regulated kinases 1/2 (ERK1/2), which promote cellular proliferation and survival. Arrestins may also engage ERK1/2 in isolation in a pre- or post-signaling complex that is likely in equilibrium with the full signal initiation complex. Molecular details of these binary complexes remain unknown. Here, we investigate the molecular mechanisms whereby arrestin-2 and arrestin-3 (a.k.a. β-arrestin1 and β-arrestin2, respectively) engage ERK1/2 in pairwise interactions. We find that purified arrestin-3 binds ERK2 more avidly than arrestin-2. A combination of biophysical techniques and peptide array analysis demonstrates that the molecular basis in this difference of binding strength is that the two non-visual arrestins bind ERK2 via different parts of the molecule. We propose a structural model of the ERK2-arrestin-3 complex in solution using size-exclusion chromatography coupled to small angle X-ray scattering (SEC-SAXS). This binary complex exhibits conformational heterogeneity. We speculate that this drives the equilibrium either toward the full signaling complex with receptor-bound arrestin at the membrane or toward full dissociation in the cytoplasm. As ERK1/2 regulates cell migration, proliferation, and survival, understanding complexes that relate to its activation could be exploited to control cell fate.</pubmed_abstract><journal>Journal of molecular biology</journal><pubmed_title>The Two Non-Visual Arrestins Engage ERK2 Differently.</pubmed_title><pmcid>PMC8977243</pmcid><funding_grant_id>R01 GM120569</funding_grant_id><funding_grant_id>R01 EY011500</funding_grant_id><funding_grant_id>16PRE30180007</funding_grant_id><funding_grant_id>P41 EB001980</funding_grant_id><funding_grant_id>T32 GM008320</funding_grant_id><funding_grant_id>S10 OD018090</funding_grant_id><funding_grant_id>18PRE34030017</funding_grant_id><funding_grant_id>P41 GM103622</funding_grant_id><funding_grant_id>R21 DA043680</funding_grant_id><funding_grant_id>R35 GM122491</funding_grant_id><funding_grant_id>P30 EY008126</funding_grant_id><funding_grant_id>R01 GM123252</funding_grant_id><pubmed_authors>Sharma P</pubmed_authors><pubmed_authors>Klug CS</pubmed_authors><pubmed_authors>Iverson TM</pubmed_authors><pubmed_authors>Zhuo Y</pubmed_authors><pubmed_authors>Kaya AI</pubmed_authors><pubmed_authors>Vishnivetskiy SA</pubmed_authors><pubmed_authors>Dalby KN</pubmed_authors><pubmed_authors>Hopkins JB</pubmed_authors><pubmed_authors>Schultz KM</pubmed_authors><pubmed_authors>Perry-Hauser NA</pubmed_authors><pubmed_authors>Zheng C</pubmed_authors><pubmed_authors>Perez I</pubmed_authors><pubmed_authors>Gurevich VV</pubmed_authors><pubmed_authors>Chung KY</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Two Non-Visual Arrestins Engage ERK2 Differently.</name><description>Arrestin binding to active phosphorylated G protein-coupled receptors terminates G protein coupling and initiates another wave of signaling. Among the effectors that bind directly to receptor-associated arrestins are extracellular signal-regulated kinases 1/2 (ERK1/2), which promote cellular proliferation and survival. Arrestins may also engage ERK1/2 in isolation in a pre- or post-signaling complex that is likely in equilibrium with the full signal initiation complex. Molecular details of these binary complexes remain unknown. Here, we investigate the molecular mechanisms whereby arrestin-2 and arrestin-3 (a.k.a. β-arrestin1 and β-arrestin2, respectively) engage ERK1/2 in pairwise interactions. We find that purified arrestin-3 binds ERK2 more avidly than arrestin-2. A combination of biophysical techniques and peptide array analysis demonstrates that the molecular basis in this difference of binding strength is that the two non-visual arrestins bind ERK2 via different parts of the molecule. We propose a structural model of the ERK2-arrestin-3 complex in solution using size-exclusion chromatography coupled to small angle X-ray scattering (SEC-SAXS). This binary complex exhibits conformational heterogeneity. We speculate that this drives the equilibrium either toward the full signaling complex with receptor-bound arrestin at the membrane or toward full dissociation in the cytoplasm. As ERK1/2 regulates cell migration, proliferation, and survival, understanding complexes that relate to its activation could be exploited to control cell fate.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-05-09T22:22:51.268Z</modification><creation>2025-02-19T04:46:09.484Z</creation></dates><accession>S-EPMC8977243</accession><cross_references><pubmed>35077767</pubmed><doi>10.1016/j.jmb.2022.167465</doi></cross_references></HashMap>